Clinical risk management of herb–drug interactions
- 20 November 2006
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 63 (3) , 258-267
- https://doi.org/10.1111/j.1365-2125.2006.02797.x
Abstract
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.Keywords
This publication has 59 references indexed in Scilit:
- Evidence-based drug–herbal interactionsLife Sciences, 2006
- Clinical Risk Management in Dutch Community PharmaciesDrug Safety, 2006
- Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug ResistanceClinical Pharmacokinetics, 2005
- Clinical Relevance of Drug-Drug InteractionsDrug Safety, 2005
- Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community PharmaciesDrug Safety, 2005
- Herb-Drug InteractionsDrugs, 2005
- Evaluation of the clinical value of pharmacists’ modifications of prescription errorsBritish Journal of Clinical Pharmacology, 2004
- Pharmacokinetic Interactions of Drugs with St John’s WortJournal of Psychopharmacology, 2004
- Pharmacovigilance of Herbal MedicinesDrug Safety, 2003
- Letters to the EditorPublished by Wiley ,1999